Series B Funding Announcements

Corgi, an AI-powered insurance startup, reportedly raised funds at a $4 billion valuation after another round of Series B funding, marking its second extension within eight weeks. The company is known for its rapid claims processing and smart liability coverage using risk retention groups.

Bunch, a German WealthTech company providing infrastructure for European private markets, raised $35 million in a Series B round, marking one of the biggest WealthTech deals of the quarter.

Crystalys Therapeutics secures $130M Series B round to advance its biopharmaceutical innovations.

Sereact's Series B funding round reaches $116 million with strategic investment from Zalando.

Cashea nets $60M Series B round to enhance its financial technology services.

Meshy nets $400M Series B round to expand its artificial intelligence capabilities.

Outset has raised a $30 million Series B funding round led by Radical Ventures, with participation from M12, Microsoft's venture arm, and existing investors 8VC, Y Combinator, and Adverb Ventures. This funding aims to support Outset's growth as an AI-native customer experience management platform.

Outset has raised a $30 million Series B funding round led by Radical Ventures, with participation from M12, Microsoft's venture arm, and existing investors 8VC, Y Combinator, and Adverb Ventures. This funding aims to support Outset's growth as an AI-native customer experience management platform.

Outset raised a $30 million Series B round led by Radical Ventures, with participation from M12 (Microsoft's venture arm), 8VC, Y Combinator, and Adverb Ventures. The funding aims to establish Outset as the first AI-native customer experience management platform.

xCures, a healthcare data company, closed a $46 million Series B financing round led by Innovius Capital, with participation from iGrow, GKCC, Spring Mountain Capital, and existing investors. The funding will support the expansion of their platform that transforms fragmented medical records into decision-ready clinical data.